These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 33333121

  • 1. Lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition.
    Suzuki Y, Onuma H, Sato R, Sato Y, Hashiba A, Maeki M, Tokeshi M, Kayesh MEH, Kohara M, Tsukiyama-Kohara K, Harashima H.
    J Control Release; 2021 Feb 10; 330():61-71. PubMed ID: 33333121
    [Abstract] [Full Text] [Related]

  • 2. Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.
    Onuma H, Sato Y, Harashima H.
    J Control Release; 2023 Mar 10; 355():406-416. PubMed ID: 36773957
    [Abstract] [Full Text] [Related]

  • 3. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X, Shi W, Geng LZ, Xu JP.
    Yi Chuan; 2020 Jun 20; 42(6):556-564. PubMed ID: 32694114
    [Abstract] [Full Text] [Related]

  • 4. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication.
    Zhang J, Zhang Y, Khanal S, Cao D, Zhao J, Dang X, Nguyen LNT, Schank M, Wu XY, Jiang Y, Ning S, Wang L, El Gazzar M, Moorman JP, Guo H, Yao ZQ.
    J Med Virol; 2023 Jul 20; 95(7):e28952. PubMed ID: 37455550
    [Abstract] [Full Text] [Related]

  • 5. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
    Moyo B, Bloom K, Scott T, Ely A, Arbuthnot P.
    Virus Res; 2018 Jan 15; 244():311-320. PubMed ID: 28087399
    [Abstract] [Full Text] [Related]

  • 6. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D, Ramadan L, Kruglova N.
    Viruses; 2023 Mar 06; 15(3):. PubMed ID: 36992399
    [Abstract] [Full Text] [Related]

  • 7. In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update.
    Kayesh MEH, Hashem MA, Kohara M, Tsukiyama-Kohara K.
    Front Microbiol; 2022 Mar 06; 13():953218. PubMed ID: 35847068
    [Abstract] [Full Text] [Related]

  • 8. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas.
    Yang YC, Yang HC.
    Viruses; 2021 Dec 21; 14(1):. PubMed ID: 35062208
    [Abstract] [Full Text] [Related]

  • 9. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD, Liang QF, Li ZY, Zhao CY.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov 20; 26(11):860-864. PubMed ID: 30616324
    [Abstract] [Full Text] [Related]

  • 10. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
    Ohno M, Otsuka M, Kishikawa T, Yoshikawa T, Takata A, Koike K.
    World J Gastroenterol; 2015 Jun 21; 21(23):7084-8. PubMed ID: 26109795
    [Abstract] [Full Text] [Related]

  • 11. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H, Choi J, Won KH.
    BMC Plant Biol; 2020 Oct 01; 20(1):449. PubMed ID: 33004008
    [Abstract] [Full Text] [Related]

  • 12. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
    Mirjalili Mohanna SZ, Djaksigulova D, Hill AM, Wagner PK, Simpson EM, Leavitt BR.
    J Control Release; 2022 Oct 01; 350():401-413. PubMed ID: 36029893
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
    Wan T, Chen Y, Pan Q, Xu X, Kang Y, Gao X, Huang F, Wu C, Ping Y.
    J Control Release; 2020 Jun 10; 322():236-247. PubMed ID: 32169537
    [Abstract] [Full Text] [Related]

  • 15. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H, Khirallah J, Li Y, Xu Q.
    Adv Drug Deliv Rev; 2022 Feb 10; 181():114087. PubMed ID: 34942274
    [Abstract] [Full Text] [Related]

  • 16. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.
    Kennedy EM, Bassit LC, Mueller H, Kornepati AVR, Bogerd HP, Nie T, Chatterjee P, Javanbakht H, Schinazi RF, Cullen BR.
    Virology; 2015 Feb 10; 476():196-205. PubMed ID: 25553515
    [Abstract] [Full Text] [Related]

  • 17. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
    Fang H, Culver JN, Niedz RP, Qi Y.
    Methods Mol Biol; 2023 Feb 10; 2653():153-171. PubMed ID: 36995625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.